6don MSN
Seeing thyroid cancer in a new light: When AI meets label-free imaging in the operating room
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
Company experiencing strong demand in the U.S. following FDA marketing authorization of ProSense® as the only on-label ...
The Chosun Ilbo on MSNOpinion
End of 50-year herbicide myth in global agriculture
In October 1901, John Francis Queeny acquired a factory site in St. Louis, United States. Having worked for 30 years at the ...
The procedure is based around dynamic optical contrast microscopy (DOCI), a technique in development at UCLA since 2016. It ...
The latest Dietary Guidelines for Americans will say that American diets should still contain no more than 10% of calories ...
Foodborne infections persist, but chemical exposure and ultraprocessed foods now play a larger role in shaping long-term ...
News-Medical.Net on MSN
AI-powered optical imaging helps surgeons identify thyroid cancer in real time
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
The National Testing Agency (NTA) has issued the subject wise NEET 2026 syllabus on this website soon after the NMC released ...
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
HER2CLIMB-05 trial evaluated Tukysa in combination with Herceptin and Perjeta for HER2-positive metastatic breast cancer, ...
Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback